E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
If approved, BOTOX Cosmetic would become the only neurotoxin with five aesthetic indications and the first and only approved for masseter muscle prominence in the US.
imphoenix82
Researchers said the new stretchable organic electrochemical transistor could be used in smart electronic skin, wearable health monitors and soft bioelectronic implants.
imphoenix82
Pro-Daptive SensorCell from Blue Chip Medical Products addresses several practical limitations associated with Air Fluidized Therapy, including surface instability, difficult patient repositioning and transfers, increased insensible fluid loss, and high acquisition and maintenance costs.
imphoenix82
The ANVISA GMP certification will help Innogen accelerate the registration and commercial launch of Efsubaglutide alfa across all PIC/S-aligned emerging markets, including Hong Kong, Southeast Asia and Latin America.
imphoenix82
Lilly is currently evaluating olomorasib in the Phase 1/2 LOXO-RAS-20001 trial involving patients with KRAS G12C-mutant non-small cell lung cancer (NSCLC) and other advanced solid tumours.
imphoenix82
A multidisciplinary transplant team at Jupiter Hospital successfully conducted robotic kidney transplant surgeries on two patients with end-stage kidney disease using the Toumai robotic surgical system from MicroPort MedBot.
imphoenix82
Fresenius Kabi holds the exclusive rights to commercialize Dr. Reddy’s Rituximab Biosimilar in the United States.
imphoenix82
Johnson & Johnson’s MONARCH Platform helps improve early lung cancer detection by enabling physicians to access and biopsy suspicious lung nodules that are difficult to reach with conventional bronchoscopy.
imphoenix82
The first edition of Pharmapack Asia is expected to attract more than 2,500 attendees, 120 exhibitors and visitors from over 40 countries
imphoenix82
The launch of Biocon’s Yesafili expands the availability of biosimilar aflibercept 2 mg for patients with age-related macular degeneration and other serious eye conditions in the US.
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
